Organon & annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Organon & Free Cash Flow (FCF) History (OGN)
Organon & reported $538.0M in free cash flow for fiscal 2025, a decrease of 29.58% from the previous fiscal year, with a free cash flow margin of 8.66%.
View full Organon & company overviewOrganon & free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $538.0M | −$226.0M | −29.58% | +8.66% |
| 2024 | 2024-12-31 | $764.0M | $216.0M | +39.42% | +11.93% |
| 2023 | 2023-12-31 | $548.0M | −$114.0M | −17.22% | +8.75% |
| 2022 | 2022-12-31 | $662.0M | −$1.31B | −66.36% | +10.72% |
| 2021 | 2021-12-31 | $1.97B | −$61.0M | −3.01% | +31.22% |
| 2020 | 2020-12-31 | $2.03B | −$899.0M | −30.70% | +31.06% |
| 2019 | 2019-12-31 | $2.93B | — | — | +37.65% |
Organon & quarterly free cash flow
Q1.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $65.0M | −$116.0M | −64.09% | +4.17% |
| Q1 2026 | 2026-03-31 | $188.0M | $145.0M | +337.21% | +12.88% |
| Q4 2025 | 2025-12-31 | $96.0M | −$239.0M | −71.34% | +6.37% |
| Q3 2025 | 2025-09-30 | $218.0M | $119.0M | +120.20% | +13.61% |
| Q2 2025 | 2025-06-30 | $181.0M | −$119.0M | −39.67% | +11.36% |
| Q1 2025 | 2025-03-31 | $43.0M | $13.0M | +43.33% | +2.84% |
| Q4 2024 | 2024-12-31 | $335.0M | $17.0M | +5.35% | +21.04% |
| Q3 2024 | 2024-09-30 | $99.0M | −$107.0M | −51.94% | +6.26% |
| Q2 2024 | 2024-06-30 | $300.0M | $344.0M | — | +18.67% |
| Q1 2024 | 2024-03-31 | $30.0M | −$38.0M | −55.88% | +1.85% |
| Q4 2023 | 2023-12-31 | $318.0M | $114.0M | +55.88% | +19.90% |
| Q3 2023 | 2023-09-30 | $206.0M | −$56.0M | −21.37% | +13.56% |
| Q2 2023 | 2023-06-30 | −$44.0M | −$150.0M | — | −2.74% |
| Q1 2023 | 2023-03-31 | $68.0M | −$22.0M | −24.44% | +4.42% |
| Q4 2022 | 2022-12-31 | $204.0M | $216.0M | — | +13.74% |
| Q3 2022 | 2022-09-30 | $262.0M | −$70.0M | −21.08% | +17.05% |
| Q2 2022 | 2022-06-30 | $106.0M | −$280.0M | −72.54% | +6.69% |
| Q1 2022 | 2022-03-31 | $90.0M | −$1.17B | −92.87% | +5.74% |
| Q4 2021 | 2021-12-31 | −$12.0M | −$285.0M | — | −0.75% |
| Q3 2021 | 2021-09-30 | $332.0M | −$375.0M | −53.04% | +20.75% |
| Q2 2021 | 2021-06-30 | $386.0M | — | — | +24.20% |
| Q1 2021 | 2021-03-31 | $1.26B | — | — | +83.80% |
| Q3 2020 | 2020-09-30 | $273.0M | — | — | +16.92% |
| Q1 2020 | 2020-03-31 | $707.0M | — | — | +39.72% |
Organon & free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $2.03B to $538.0M, a compound annual decline of 23.32%. Organon &'s latest reported quarter, Q2 2026, generated $65.0M in free cash flow, a decrease of 64.09% year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Organon & filings at SEC.gov ↗